<%@LANGUAGE="VBSCRIPT" CODEPAGE="1252"%> Sun Pharma Advanced Research Company Ltd. - Annual Report 07-08
HOME   |   BOARD OF DIRECTORS   |   NCE PROJECTS   |   NDDS   |   DIRECTORS' REPORT   |   FINANCIAL SECTION   |   CONTACT   |   CONTENT
     
  Dry Powder Inhaler Device  
  Controlled Release Devices  
  Nanoemulsion  
  Biodegradable Depot  
  A novel drug delivery system offers improved patient compliance by changing the manner in which a drug is absorbed or distributed in the body.  
  Because of the changed nature of the release pattern, an extended release drug is able to use less total drug over time compared to a conventional preparation.  
The advantages are a decrease or elimination of local or systemic side effects, less tolerance development with chronic use, minimization of drug accumulation in body tissues with chronic dosing.
The most important advantage is improved efficiency in treatment because constant or some other pattern of drug release can be obtained promptly and maintained over a long period. Reducing fluctuations in the blood level also allows better disease management.